RxDoctor Payments Data

Laura Blechner

Physician Assistant · Philadelphia, PANPI 1740490663

Payments from drug & device makers

$4,124in general payments, 2019–2025

Across 210 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$932
  • AbbVie$566
  • Novo Nordisk$439
  • Abbott$308
  • AstraZeneca$299
  • Exact Sciences$219
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,124 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$65,890
Trelegy ElliptaFluticasone/Umeclidin/Vilanter90$62,904
EntrestoSacubitril/Valsartan48$31,917
EliquisApixaban53$31,490
JardianceEmpagliflozin27$21,865
VraylarCariprazine Hcl15$21,257
MovantikNaloxegol Oxalate46$18,459
XareltoRivaroxaban21$18,093
FarxigaDapagliflozin Propanediol23$14,489
JanuviaSitagliptin Phosphate20$14,381
MyrbetriqMirabegron30$12,905
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$12,611
TrulicityDulaglutide13$12,053
SantylCollagenase Clostridium Hist.14$9,411
Triamcinolone Acetonide22$9,306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$932$75,515117 claims
Novo NordiskOzempic$439$65,89067 claims
PfizerEliquis$45$31,49053 claims
AstraZenecaFarxiga, Breztri Aerosphere$299$22,15635 claims
Boehringer IngelheimJardiance$135$21,86527 claims
AbbVieVraylar$566$21,25715 claims
Lilly USA, LLCTrulicity$172$12,05313 claims
Smith+NephewSantyl$33$9,41114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →